The efficacy of pacemaker implantation for extracardiac total cavopulmonary connection in a pediatric patient with bradycardia-tachycardia syndrome

Published:November 22, 2021DOI:


      A 9-year-old boy, diagnosed with double outlet right ventricle after birth, suffered sinus node dysfunction and non-sustained junctional tachycardia after an extracardiac total cavopulmonary connection (TCPC). Spontaneous atrial tachycardia appeared 3 years after an extracardiac TCPC. Sotalol was administered but the bradycardia was obvious. It was difficult to increase sotalol and atrial tachycardia was uncontrollable. Atrial tachycardia continued with symptoms; direct current (DC) cardioversion was frequently required. Five years after extracardiac TCPC, we implanted a pacemaker with atrial antitachycardia pacing (ATP) using epicardial leads. On day 2 post operation, wide QRS tachycardia appeared. Due to decreased blood pressure, DC cardioversion was immediately performed, but it recurred from atrial premature contraction. We judged this was atrial tachycardia with 1:1 atrioventricular conduction based on an intracardiac electrogram and it was terminated by burst atrial pacing from the pacemaker. After changing atrial pacing rate to 150 ppm, atrial tachycardia could be suppressed. Due to atrial pacing and increasing sotalol gradually, junctional tachycardia terminated spontaneously, and atrial tachycardia was not induced after pacemaker implantation. In conclusion, implantation of a pacemaker with ATP and intensification of antiarrhythmic drugs is an effective treatment strategy for pediatric patients with bradycardia-tachycardia syndrome after extracardiac TCPC.


      To read this article in full you will need to make a payment


        • Rychik J
        • Atz AM
        • Celermajer DS
        • Deal BJ
        • Gatzoulis MA
        • Gewillig MH
        • Hsia TY
        • Hsu DT
        • Kovacs AH
        • McCrindle BW
        • Newburger JW
        • Pike NA
        • Rodefeld M
        • Rosenthal DN
        • Schumacher KR
        • et al.
        Evaluation and management of the child and adult with Fontan circulation: a scientific statement from the American heart association.
        Circulation. 2019; (Jul 1:CIR0000000000000696Online ahead of print)
        • Fujita S
        • Takahashi K
        • Takeuchi D
        • Manaka T
        • Shoda M
        • Hagiwara N
        • Kurosawa H
        • Nakanishi T.
        Management of late atrial tachyarrhythmia long after Fontan operation.
        J Cardiol. 2009; 53: 410-416
        • Janson CM
        • Shah MJ.
        Supraventricular tachycardia in adult congenital heart disease: mechanisms, diagnosis, and clinical aspects.
        Card Electrophysiol Clin. 2017; 9: 189-211
        • Triedman JK
        • Alexander ME
        • Love BA
        • Collins KK
        • Berul CI
        • Bevilacqua LM
        • Walsh EP.
        Influence of patient factors and ablative technologies on outcomes of radiofrequency ablation of intra-atrial re-entrant tachycardia in patients with congenital heart disease.
        J Am Coll Cardiol. 2002; 39: 1827-1835
        • Newcombe J
        • Gordon B
        • Razzouk A
        • Bailey L
        • Mandapati R.
        Extracardiac autologous pericardial tunnel Fontan allows implantation of an endocardial atrial lead for sinus node dysfunction.
        Ann Thorac Surg. 2014; 98: 1094-1096
        • Kramer CC
        • Maldonado JR
        • Olson MD
        • Gingerich JC
        • Ochoa LA
        • Law IH.
        Safety and efficacy of atrial antitachycardia pacing in congenital heart disease.
        Heart Rhythm. 2018; 15: 543-547
        • Kamp AN
        • LaPage MJ
        • Serwer GA
        • Dick 2nd, M
        • Bradley DJ
        Antitachycardia pacemakers in congenital heart disease.
        Congenit Heart Dis. 2015; 10: 180-184
        • Drago F
        • Silvetti MS
        • Grutter G
        • De Santis A.
        Long term management of atrial arrhythmias in young patients with sick sinus syndrome undergoing early operation to correct congenital heart disease.
        Europace. 2006; 8: 488-494
        • Tsao S
        • Deal BJ
        • Backer CL
        • Ward K
        • Franklin WH
        • Mavroudis C.
        Device management of arrhythmias after Fontan conversion.
        J Thorac Cardiovasc Surg. 2009; 138: 937-940
        • Miyazaki A
        • Ohuchi H
        • Kurosaki K
        • Kamakura S
        • Yagihara T
        • Yamada O.
        Efficacy and safety of sotalol for refractory tachyarrhythmias in congenital heart disease.
        Circ J. 2008; 72: 1998-2003